During the past decade, Universitätsmedizin der Johannes Gutenberg-Universität Mainz conducted 250 clinical trials. In the 10-year time frame, 250 clinical trials started and 115 clinical trials were completed, i.e. on average, 46% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 74 clinical trials were completed. i.e. 77.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" #1 sponsor was "Boehringer Ingelheim" with 22 trials, followed by "Abbott Medical Devices" with 15 trials sponsored, "Pfizer" with 12 trials sponsored, "Celgene" with 11 trials sponsored and "University of Ulm" with 11 trials sponsored. Other sponsors include 294 different institutions and companies that sponsored additional 182 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 4 trials as a collaborator. Other collaborators include 223 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" are "Multiple Myeloma" (13 trials), "Coronary Artery Disease" (9 trials), "Acute Myeloid Leukemia" (8 trials), "Heart Failure" (7 trials) and "Psoriasis" (7 trials). Many other conditions were trialed in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" are "Drug" (271 trials), "Device" (54 trials), "Biological" (28 trials), "Other" (28 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (77 trials), "Carboplatin" (10 trials), "Atezolizumab" (8 trials), "Dexamethasone" (8 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz" are 348 trials for "All" genders, 13 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz". undefined are not yet recruiting, 78 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 177 completed trials in Universitätsmedizin der Johannes Gutenberg-Universität Mainz, 1 suspended trials, and 44 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin der Johannes Gutenberg-Universität Mainz, 24 "Phase 1" clinical trials were conducted, 126 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 30 trials that are defined as “Not Applicable".

Universitätsmedizin der Johannes Gutenberg-Universität Mainz has several departments that took part in Clinical trials: "Center of Cardiology, Cardiology I, university hospital Mainz" - 7 trials, "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Medizinische Klinik, Pneumologie" - 5 trials, "Klinikum der Johannes Gutenberg Uni Mainz; Studienz. Neurologie, Klinik und Poliklinik Neurologie" - 4 trials, "University Medical Center, Department of Psychosomatic Medicine and Psychotherapy, Johannes Gutenberg University" - 3 trials, "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" - 4 trials, "Department of Gynecology and Obstetrics, University Medicine Mainz" - 2 trials, "Universitätsmedizin Mainz, Klinik und Poliklinik für Neurologie" - 2 trials, "Mainz Comprehensive Epilepsy and Sleep Medicine Center" - 2 trials, "Dr. Eva Wittenmeier" - 2 trials, "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kinder- und Jugendmedizin, Pädiatrische Hämatologie / Onkologie" - 2 trials, "Universitätsmedizin derJohannes Gutenberg-Universität Mainz;Klinik für Psychiatrie und Psychotherapi" - 2 trials, "Universitaetsmedizin der Johannes-Gutenberg-Universitaet Mainz, Zentrum für Kardiologie I, Centrum für Thrombose und Hämostase (CTH), Langenbeckstrasse 1" - 2 trials